Ageing and stress have been identified as potential contributors to inflammation. While stress-related inflammation often subsides on its own, there are instances where it evolves into a chronic condition. Prolonged or chronic inflammation can give rise to severe health issues, causing irreversible damage to the body. SENEX aims to disrupt the cycle of chronic inflammation through the utilization of AAV-mediated gene therapy. Initially, the company is concentrating its efforts on addressing Pulmonary Arterial Hypertension and Osteoarthritis.

Senex Therapeutics

Org chart

Teams

Offices